Bavarian Nordic A/S BV3
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryDenmark
Employees1,861
TickerBV3
Statistics
Market Cap$2.17B
Revenue (TTM)$6.92B
Net Income—
Net Margin—
EPS—
P/E12.10
P/S0.31
P/B1.11
EV/EBITDA-0.19
ROE9.7%
Dividend Yield—
Price$28.14
Data: Twelve Data · Revenue = mcap / P/S